About us

SwedenBIO was founded in 2002 by the CEOs of seven leading Swedish life science companies: Amersham Biosciences (now GE Healthcare), Active Biotech, Biovitrum (now SOBI), KaroBIO, Medivir, Melacure Therapeutics and Pharmacia Diagnostics (now Thermofisher).

A service that is now run together with several organizations around the country, with funding from Tillväxtverket and Vinnova. SwedenBIO provides life science-specific expertise and advice on EU applications.

You can read our reports here.

Read more about the SwedenBIO Award here.

Read more about Nordic Life Science Days here.

The three industry organizations LIF, Swedish Medtech and SwedenBIO present a joint action plan for life science. The action plan consists of 25 measures to strengthen Sweden’s competitiveness. The action plan will be revised in 2018.

Read more about how we work to give the life sciences industry a strong voice.

Link to 3.3. representation

An advisory material to help companies find the right minimum level of information to provide about their projects when seeking new capital.

Read our updated industry standard on fundraising in life sciences here.

Our members

SwedenBIO goes international – Nordic consortium formed

Link to the international page

Intensive policy work in the life science office’s thematic groups. Ahead of the release of the life science strategy, etc.

SKR and the life science industry have signed two agreements to develop work on clinical trials and quality registers.

Three comprehensive industry analyses are being produced

What is the financial landscape? What is precision medicine and which companies are developing new drugs and vaccines? Link to reports.

Our members